Otsuka Holdings Co., Ltd.

4578・Prime Market・Pharmaceuticals

Official website

Otsuka Holdings Co., Ltd.

4578・Prime Market・Pharmaceuticals

Official website

Otsuka Holdings Co., Ltd.4578

Reference Indicators

Market Cap

60,163¥100M

P/E (Forecast)

—

P/B

1.9x

Dividend Yield (Forecast)

1.26%

ROE

12.0%

EV/EBITDA

9.3x

Financial Summary

Unit: ¥M

Item	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Net Sales	1,498,276	1,737,998	2,018,568	2,329,861	2,468,892
Cost of Sales	495,030	569,501	611,219	660,432	699,115
Gross Profit	1,003,245	1,168,496	1,407,348	1,669,428	1,769,776
SG&A Expenses	622,326	724,129	807,355	958,345	1,004,505
Operating Income	154,497	150,323	139,612	323,564	479,375
Pre-tax Income	163,638	172,954	142,655	335,854	468,037
Income Taxes	34,429	35,534	17,155	-11,417	101,821
Net Income	125,463	134,019	121,616	343,120	363,150
EBITDA	239,352	244,084	237,389	431,543	595,542
Gross Margin	67.0%	67.2%	69.7%	71.7%	71.7%
Operating Margin	10.3%	8.6%	6.9%	13.9%	19.4%
ROA	4.4%	4.3%	3.6%	9.2%	8.7%
ROE	6.2%	6.0%	5.1%	12.6%	12.0%

Segment Performance

Unit: ¥M

2026

Segment	Net Sales	Operating Income	Operating Margin
医療関連事業	1,744,234	445,302	25.5%
ニュートラシューティカルズ関連事業	577,621	57,719	10.0%
消費者関連事業	34,610	25,150	72.7%
その他の事業	112,426	7,984	7.1%